one of only a few truly multidisciplinary evidence-based practice texts to meet the needs of undergraduate and postgraduate students enrolled in inter-professional courses.
Sydney, New South Wales (PRWEB) April 18, 2013
A fully revised new edition of 'Evidence-Based Practice Across the Health Professions' will help even more health professions students find and use evidence to inform their decision-making in future careers.
Completely updated and expanded, this second edition covers three new health disciplines – human movement & exercise science, pharmacy and paramedicine – bringing the book’s total to 12.
This edition’s extensive new content addresses current trends in health professional education, appealing to a greater proportion of students and introductory clinicians.
Though evidence-based practice is now commonplace in most health professions, this second edition addresses criticism of the practice.
Additional new material in this larger-format paperback includes: a chapter on embedding evidence-based practice into routine clinical care; new clinical scenarios; and more examples of systematic reviews.
Coupled with the wealth of respected content carried over from the first edition, this new material will help arm students with the knowledge and skills required to become committed evidence-based clinicians who understand the importance and implications of evidence-based practice in the overall healthcare environment.
Published four years after its first edition, this new edition of 'Evidence-based Practice Across the Health Professions' remains one of only a few truly multidisciplinary evidence-based practice texts to meet the needs of undergraduate and postgraduate students enrolled in inter-professional courses.
The book is again written by local authors Tammy Hoffman, Sally Bennett and Chris Del Mar, assisted by an impressive list of Australian and international expert contributors writing on topics such as nursing, CAMS and qualitative evidence-based practice.
Summary points at chapter-end and complementary content on Elsevier’s Evolve platform will further assist students learning to source the best-available evidence to support key decisions on patient care.
ABOUT THE AUTHORS
Tammy Hoffmann BOccThy(Hons), PhD
Dr Hoffman is Associate Professor of Clinical Epidemiology at Bond University’s Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine (Gold Coast, Australia). She is an NHMRC/PHCRED Career Development Research Fellow within the School of Health and Rehabilitation Sciences at the University of Queensland (Brisbane, Australia).
Sally Bennett BOccThy(Hons), PhD
Dr Bennett works at the University of Queensland as a Senior Lecturer and Senior Research Fellow, within the Division of Occupational Therapy, School of Health and Rehabilitation Sciences.
Chris Del Mar BSc, MA, MB BChir, MD, FRACGP, FAFPHM
Dr Del Mar is Professor of Public Health and academic general practitioner at Bond University’s Centre for Research in Evidence-Based Practice, Faculty of Health Sciences and Medicine (Gold Coast, Australia).
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).